Scilex Holding Company Other Current Liabilities
Scilex Holding Company (SCLX) had Other Current Liabilities of $3.26 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:OtherLiabilitiesCurrent · last filed 2026-08-14
- 2026-06-30: Other Liabilities, Current $3.26M.
- 2026-03-31: Other Liabilities, Current $255.00K.
- 2025-12-31: Other Liabilities, Current $3.26M.
- 2025-09-30: Other Liabilities, Current $5.74M.
| Period end | Other Liabilities, Current | Other Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $3.26M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $255.00K 10-Q · filed 2026-05-20 | |
| 2025-12-31 | $3.26M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $5.74M 10-Q · filed 2025-11-14 | |
| 2024-12-31 | $0.00 10-K · filed 2026-04-10 | $9.60M 10-Q · filed 2025-11-14 |
| 2023-06-30 | $18.44M 10-Q · filed 2023-08-11 | |
| 2023-03-31 | $9.60M 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $0.00 10-Q · filed 2023-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |